Cargando…
The prevention and treatment of COVID-19 in patients treated with hemodialysis
Patients treated with hemodialysis are often immunocompromised due to concomitant disease. As a result, this population is at high risk of infection and mortality from COVID-19. In addition to symptomatic treatment, a series of antiviral drugs targeting COVID-19 are now emerging. However, these anti...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10563282/ https://www.ncbi.nlm.nih.gov/pubmed/37814329 http://dx.doi.org/10.1186/s40001-023-01389-9 |